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Calcium entry into Xenopus oocyte occurs mainly through voltaSe-dependcnt alcium channels. These channels were characterized asheIon& 
to a particular type of calcium channel insensitive to dihydropyridines, m-conotoxin, and Agdenop~ts aperfa venom, but blocked by divalent cations 
(Co, Cd, Ni). Intracellular injection of CAMP, or bath application of phorbol ester, induced a marked increase in calcium current amplitude and 
a slowing of the inactivation time-course. Despite their different pharmacology, endogenoue calcium channels, like cardiac or neuronal calcium 
channels, could bc thus regulated by protein kinases A and C. 
Calcium channel; Oocyte; Phosphorylation; Protein kinasc A; Protein kinase C 
1. INTRODUCTION 
Xenopus oocytes have been developed as an efficient 
expression system in the early 70’s [l]. They are now 
widely used to express soluble proteins as well as 
membrane receptors and ion channcis after injection of 
either total (or poly (A)*) or in vitro transcribed RNA 
from cloned proteins [2]. One of the most interesting 
features of the Xefiopus oocyte to study ion channels is 
the fact that it possesses only a few endogenous’ con- 
ductances, especially when follicular cells are emymati- 
tally removed [3,4]. However several groups have 
reported the existence of different conductances to Cl-, 
Na+, K”, and even Ca2* [5-123. Such conductances can 
constitute disturbing background ionic ‘noise’, when 
one wants to record ionic current from expressed, ex- 
ogenous RNA-directed, channels. This is especially true 
for the voltage-dependent calcium channels (VDCC) 
which belong to a different class than usual Ca channels 
found in other tissue, as evidenced by their specific 
pharmacology characterized by the absence of potent 
inhibitors. Dascal et al. [I l], Moorman et al. [IO], Lory 
et al. [13] have reported that these Ca channels are 
blocked neither by dihydropyridine (DHP) nor by the 
usual toxins used to differentiate VDCC (w-conotoxin). 
Such observations indicate that endogenous calcium 
channels could represent a new class of VDCC. More- 
over, up to now, no study has focussed on the intracel- 
lular regulation of these channels despite the fact that 
regulations of Ca channels expressed from heart or 
brain RNA, [11,14] have been performed in Xenopus 
oocytes. It has also been reported that these oocytes 
possess the complete intracellular machinery for protein 
phosphorylation either by kinases A or C [2]. Indeed, 
study on the regulation of cloned channels after injec- 
tion of cRNA coding for Na or K channels, and there- 
fore without injection of messenger RNA for kinases, 
has already been performed [15-171. It thus appeared 
that a more precise characterization of the pharma- 
cological properties and regulation of these Xetrctpus 
oocyte VDCCs needed to be realized. 
2. MATERIAL AND METHODS 
2.1, Oocyre prrparark7n 
Oocytes were dissected away from trieaine methane sulfonate-anes. 
thetlzed Female Xr~~opus Iuevis (from CRBM, Montpellier, France) 
and prepared as reported elsewhere [13]. Stage V and VI oocytes were 
selected For electrophysiological meesurements. Oocytes could he 
maintained For 2-6 days at 20% in a medium containing (in mM): 
NaCl96, KCI 2, MgClx 2, CatI2 I .8, Na-pyruvate 2.5, HEPES 5, pH 
7.4 with NaOH, and supplemented with SOfiglmi gentamicin. Incuba- 
tion medium was renewed aily. 
Abbreuinfions: WCC, vollagedependent calcium channels; DHP, di- 
hydropyridinc; PKA, protein kinase A; PKC, protein kinase C; 
Ag.A.V., Agelenopsis aperta venom; DAG, diacylclycerol; PMA, 
phorbol 1Zmyristate 13-acetate; OAG, oleyl-acetyl-glycerol; IBMX, 
3-isobutyl -methyl xanthine; PDBU. phorbol 12,13-dibutyrate. 
Correspondence address: P. Charnet, CNRS-CRBM, Route de Mende 
BP SOTI, 34033 Montpellier, France. Fax: (33) (67) 52 1559. 
Electrophysiological measurements were performed using the 
standard two microelectrode voltaSc-clamp technique with the TEV- 
200 Cornerstone amplifier (Dagan Instruments, Minneapolis, MN). 
Oocytes were tested l-5 days after isolation, no significant dilTerences 
were seen during this period. In most experiments he holding voltage 
was -80 mV. Stimulation of the preparation, data acquisition and 
analysis were performed using the pCLAMP software (xcer. 5.5. Axon 
instrument, Burlingame, CA). Oocytes were placed in a recording 
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ohumbcr (200~1) and impaled with 3 M CsCl~fillcd electrodes (0.1-0.5 
MR) to suppress cndogcnous K current. Drugs were applied ex- 
ternally by addition to the supcrfusatc (gravity-driven superfusion). 
For intracellular injection, oocytes were impaled with a third addi. 
tional micropipette (3-10 ,uM in tip diameter). The injection volume 
was 2-5% of the entire cell volume (1 yl) and all injected compounds 
wcrc made up in water. Experiments wet-c made at room temperature, 
Calcium-activated chloride currents (Icltca,) arc mcasurcd in a 
saline solution of the following composition (in mM): NaCl96, KCI 
2, CaCI, 1,8, MgCli 2, HEPES S. pH adjusted to 7.4 with NaOH, To 
record Ca channel activity, oocytcs wcrc rontincly tested in the follow- 
ing BAMS medium (in mM): BaOH 40, NaOH SO, CsOH 2, HEPES 
5, pH adjusted to 7.4 with methane sulphonic acid. All Ba currents 
were lcak+ubtractcd using current races recorded in the presence of 
Cd2’ (1 mM). 
2.3. Drugs 
All chemicals wcrc from Sigma (St. Louis, MI). Bay-K 8644 and 
nicardipinc were kindly provide by Sandoz-France, and stock solu- 
tions (10 mM) were made up in ethanol. Amiloride, w-conotoxin and 
funneLweb spider venom (Ag.A.V.; from Agcleno@s uperra) were 
purchased from Sigma, RBI (Natick, MA) and Latoxan.France, rem 
spcctivcly; stock solutions were made up in water, All final conccntra- 
tions were obtained by appropriate dilution in BAMS solution. Pep 
tidic protein kinase inhibitors, A-PKi, an 18 amino acid pcptide, were 
synthcsizcd at the CRBM (CNRS, Montpcllicr, France). 
2.4. Analysis 
Values are exprcsscd as mean 2 SE (number of different oocytcs 
from the same donor). Current-voltage relations (Fig. 2 and 3) were 
normalized according to the prak current obtained in control condi- 
tions (i.e. before drug application, generally at + 10 mv). Time-course 
of CAMP and PKC cffbqts were normalized according to the current 
obtained at equilibrium to allow comparison bctwcen the two 
processes (Fig. 4). In both oases real current amplitudes arc given in 
the teat. Inactivation time courses were fitted to single exponential 
decay using non-linear regression. 
3, RESULTS AND DISCUSSION 
Endogeneous Xernopus oocyte VDCC activity could 
be visualized in normal saline solution by activation of 
a Ca-activated chloride current. This current displayed 
little amplitude variation when studied on oocytes from 
the same frog, but could vary widely on oocytes from 
different donors, The variation was due, at least in part, 
to variations in the amplitude of the endogenous Ca 
current which is the primary trigger of the Cl conduct- 
ance. Indeed, when VDCC activity was recorded in 
BAMS solution, similar variations were obtained. For 
example, the Ba current (Inn) recorded during a test 
pulse to +lO mV, from a holding potential of -80 mV, 
varied from 12 f 2 nA (~7) to 33 f 2 nA (n = 8) when 
obtained from oocytes of two different frogs. In 50% of 
the frogs, no inward Ba current could be recorded at all. 
Any role of the oocyte outward K” current in this 
variance can be ruled out since we used Cs’ (instead of 
K”) in the perfusing solution (BAMS), and in the re- 
cording electrodes, Moreover, these values of IBp were 
obtained from Cd-substracted traces. The wide range of 
current amplitudes probably reflects the different meta- 
bolic stages of the oocytes between different frogs, In- 








,Amilorida / Ni Cadmium 
Fig. I. Phatxacology of endogcnous VDCC. (A) Absence of effect of 
DHP agonis! (Aa; Bay-K 8644, 1 ,DM) and antagonist (Ab; nioarm 
dipinc. 10 PM). Traocs before and after drug application super- 
imposed. (B) Endogenous VDCC was blocked neither by a, conotoxin 
(Ba; 1 PM), nor by crude Ag.A.V. (Bb; 111000 dilution, upper trace, 
10% block). (Ca) Absence of effect of amiloddc (10 PM). and nickel 
(IO PM) on control cndogcnous Ba current (three traces supcr- 
imposed). However, the current could lx blocked with higher nickel 
doses (1 mM, trace marked with l ). (Cb) Effects of various concentra- 
tions ofcadmium (1, IO, 100, IOOOpM, traces of incrcusing amplitude) 
on control Ba current (bottom trace). The dose for SO% inhibition is 
10 PM. All currents were rc.xorded in BAMS solution using voltage 
steps to 1-10 mV from a holding potential of -80 mV. Currents were 
cadmium subtracted, except for (Cb) where a P/4 leak-subtraction was 
used. Scale bar: IO nA and 200 ms. 
amplitude, always displayed the same pharmacological 
profile (see below), suggesting changes in the expression 
of a homogeneous population of VDCC, instead of dif- 
ferent populations of channels with different pharma- 
cological properties, as was seen in other preparations. 
Consistently, the inactivation time-course was not de- 
pendent upon current amplitude, and comparable in- 
activation time-constants were found for Ba currents of 
different amplitude (235 f 48 ms, and 286 -1- 57 ms, for 
the two batches of oocytes described previously). When 
all detectable ndogenous Ba currents were pooled to- 
gether, the mean inactivation time-constant was 250 f 
70 (at +lO mV, n=35). From these results we can state 
that oocytes display only a single class of calcium 
channel, Further characterization of the endogenous 
VDCC has been focussed on: (i) the effect of various 
‘classical’ calcium channel inhibitors used to separate 
the different ypes of VDCC; and (ii) the regulation of 
the endogenous VDCC by protein kinases A and C. 
Neither DMP antagonist (or agonist, 10 ,um, Fig. 
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Fig. 2. Effect of intracellular injection of CAMP. (A) Current traces 
before (open squares) and 5 min after intrncellulsr injection of CAMP 
(SO pmol, filled square). (D) Current-voltage curve for control and 
CAMP-stimulated Ba current. The holding potential was -80 mV, and 
voltage steps were generated from -50 mV to 450 mV with a 5 mV 
increment. Note the lcftward shift of the I-Y curve. All recording 
conditions were similar to Fig. 1. 
1 Aa, 1 Ab), nor wconotoxin (1 ,uM; Fig. 1Ba) blocked 
(or potentiated) the oocyte endogenous VDCC. Perfu- 
sion of Agdetzopsis apertu venom (Ag.A.V.; l/l000 dilu- 
tion) induced a slight block of the endogenous Ba 
current (13 f 8%, n = 8; Fig. lBb), and was sometimes 
without effect (n=3). The same venom has been shown 
to block more than 70% of rat brain mRNA-directed Ca 
channels [18], or Ca channels expressed after the injec- 
tion of RBl cRNA, coding for a P type Ca channel [193. 
However, the endogenous Ba current could be re- 
versibly blocked by well-known inorganic Ca blockers 
(Cd2+ or Ni2’ at 1 mM, Fig. 1Cb; Co2+ not shown). 
Endopenous VDCC can thus be considered as a parti- 
cular type of Ca channel different from the L type, N 
type and P type (for the pharmacology of these types see 
[18,20,21]). From the slow inactivation time constant 
and the high threshold potential for activation (see 
current-voltage curve Fig. 2B, for example), it seems 
also unlikely that it belongs to the T type. Consistently, 
endogenous VDCCs were not blocked by 10 ,uM Ni, but 
could be inhibited at higher (1 mM) doses, and ami- 
loride was without effect (1OpM; Fig. 1Ca). Among the 
different types of Ca channels, the L and N type have 
been shown to be the target of various protein kinases 
[18]. In the case of the protein kinases A and C, func- 
tional effects of phosphoryiation resuited in increased 
channei availability and/or open time [21,223. 
When 50 pmol of CAMP are injected into a control 
oocyte, the inward Ba current slowly increased to a new 
steady level from 24 + 7 nA to 39 + 5 nA (n=8) in 
around 5 min (Figs. 2A and 4A). This potentiation 
occurred immediately after the injection of CAMP, and 
developed concomitantly to a slowing of the inactiva- 
tion time-course. When fitted with a single exponential, 
the inactivation time constant (at -1-10 mV) increased 
from 240 f 60 ms to 521 P 240ms (n=lO). This effect 
was prevented by prior injection of the specific peptidic 
PKA inhibitor (A-PKi; [23]) showing the involvement 
of the protein kinase A (not shown). The mean normal- 
ized current-voltage curves before and after CAMP in- 
jection are shown in Fig. 2B. The maximum of the 
current-voltage curve was shifted by 10 mV in the hy- 
perpolarized irection after CAMP injection, and conse- 
quently, the increase was more pronounced for small 
depolarizations. For example, Inu was potentiated by 
3-fold at -10 mV and only by 1.6-fold at -1-10 mV. The 
regulation by CAMP of the endogenous VDCC 
appeared similar to the regulation of expressed of native 
cardiac [22,24] calcium channels. Moreover, CAMP-PO- 
tentiated Ba currents exhibited a pharmacology similar 
to unstimulated VDCC with regard to toxin, DHP in- 
hibition and divalent cation block (not shown). Similar 
increase was obtained after perfusion of the 
phosphodiesterase (PDE) inhibitor IBMX (1 mM; not 
shown), suggesting that the use of the PDE-inhibitor 
theophylline ([1 11, to prevent oocyte maturation) could 
lead to underestimation of expressed (or endogenous) 
ion channel regulation by CAMP. 
Another major regulatory pathway of the cardiac or 
neuronal VDCC is the activation of phospholipase C 
which leads to production of diacylglycerol (DAG), and 
activation of protein kinase C [22]. Such activation 
promotes channel phosphorylation producing an in- 
crease in the channel activity seen on macroscopic and 
single-channel recordings in native cells [22,25,26] or 
after mRNA expression in oocytes ([27]; Bourinet, E., 
Fournier, F., Lory, P., Chamet, P., and Nargeot, J., 
unpublished observations). Direct activation of PKC 
using extracellular application of either an analog of 
DAG (oleyl-acetyl-glycerol: GAG) or a phorbol ester 
(phorbol IZmyrystate 13-acetate: PMA) produced in 
both cases an increase in the endogenous VDCC activ- 
ity. The potentation produced by 2 PM GAG is shown 
on Fig, 3Aa for a test-pulse to + 10 mV. Basal Ba current 
increased from -24 f 5 nA to -34 1 3 nA (n=4) after 
perfusion of the drug. This effect developed with the 
same kinetics as with CAMP and steady-state potenta- 
tion was usually obtained S-10 min after the beginning 
of the perfusion. As for CAMP, the OAG-induced 
potentation was voltage-dependent, and a 10 mV hyper- 
polarizing shift of the maximum of the current-voltage 
curve was obtained (Fig. 3Ab). The mean current in- 
creased by 220% at -10 mV, 40% at +lO mV, while no 
effect was seen for potentials greater than +20 mV. 
Moreover, a slight slowing of the inactivation timc- 
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Fig. 3. Effect of PKC activation. (A) h stimulation induced by OAG. (Aa) Current traces obtained before (open squares) and I5 min after (filled 
squares) perfusion of 2pM of OAG. (Ab) Current-voltage relationship for i,, before and after perfusion of OAG. The holding potential was -80 
mV. (83 PMA (300 nM, filled squares) has similar effects to OAG on endogenous current (open squares). Note in both cases a slowing of the 
inactivation time-course. (Bb) Current+oltagc relationships for IDU before (open squares), and after (filled squares) perfusion of PMA (300 nM). 
Note the greater potentiation for small voltage steps. 
course was also noted (from 175 2 26 ms to 285 + 140 
ms, n=4). 
Using phorbol ester (PMA, 300 nM) instead of an 
analog of DAG to stimulate the protein kinase C 
produced the same effects. Basal endogenous current 
was potentiated from -28 & 6 nA to -41 I- 9 nA (~9; 
see Fig. 3 Ba), and inactivation was slowed (from 244 
k 77 ms to 450 + 171 rns, n=lS). A similar shift in the 
current-voltage relationship was obtained (Fig. 3Bb) 
toward hyperpolarizing potentials. The current in- 
creased by 200% when the voltage was stepped up to 
-10 mV, but only by 61% for voltage steps up to 1-10 
mV. PDBU (300 nM), another phorbol ester activating 
PKC, produced qualitatively and quantitatively the 
same effects (not shown). It thus appeared that PKC 
activation, using phorbol esters or analogs of DAG, 
potentiated the oocyte calcium channel activity in a 
similar way to CAMP. First the kinetics of the increase 
were identical (see Fig. 4A), and second, both induced 
a slowing of the inactivation time constant. Isoprenaline 
(or activation of protein kinase A) has been shown to 
change the inactivation time constant of cardiac alcium 
channels when Ba ions are the charge carrier, this effect 
resulting from an increase in the reopening probability 
of the channel during the test pulse [22]. Similar 
observations have not yet been made during PKC 
stimulation of either neuronal or cardiac calcium 
channels [27]. CAMP-induced potentation of Ba current 
was on average (using oocytes from the same batch) 
greater than PKC-induced potentation (65% vs. 45% at 
+lO mV; n=9 and 10, respectively), both at supramax- 
imal concentration. Moreover, while the stimulations 
were similar during the first 5-10 min, prolonged 
8 
A 
Basal Current (nA) 
Fig. 4. (A) Time-course of protein kinase induced-stimulation. Effect 
of CAMP (50 pmol injected, filled circles), OAG (2itM) or PMA (300 
nM, open squares) on IBA amplitude at various times after applica- 
tion. The PKA and PKC stimulation produced asimilar potentiation, 
with a half~maximat clkct reached in about 2-3 min. All currents were 
normalized according to the maximal current obtained at the steady- 
state efl’ect of the drug. (B) CAMP-induced potentialion is dependent 
upon basal current amplitude. The percentage of increase induced by 
PKA (CAMP, filled circles) and PKC (OAG, open triangles, and PMA 
open squares) activators is plotted against the current amplitude 
before drug application, Not* he vtiriability of ihe cants& cG?izilt, 
and the relation between CAMP-induced stimulation of the size of the 
control current. PKC-induced stimulation did not vary with current 
amplitude. Lines arc drawn through the points to illustrate the trends. 
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application of PKC agonists induced a marked run- 
down of the Ba current not obtained with long applica- 
tion of PKA agonist (not shown). A similar run-down 
has been observed on heart RNA-injected oocytes 
(Bourinet et al., unpublished observations) and on 
cardiac myocytes [26], and is attributed to a down- 
regulation of the protein kinaser C, and/or membrane 
internalization [30]. We have also found that effects of 
PKA and PKC were additive, i.e. prior injection of 
CAMP produced an increase in calcium entry evidenced 
by an increase in ICI(Cn), and subsequent application of 
PMA gave rise to an additional potentation of the 
chloride conductance (not shown). 
It could be asked whether such regulations have any 
physiological relevance. It is noteworthy that the CAMP 
effect on endogenous VDCC seemed to be related to the 
amplitude of the basal Ba current: large currents were 
less sensitive to CAMP, whereas PKC-stimulation re- 
sulted in a rather constant increase, regardless of the 
basal current amplitude (Fig. 4B). Indeed CAMP con- 
centration has been shown to play a critical role during 
oocyte maturation, and its level is regulated by G-pro- 
tein-coupled progesterone receptors. At rest, in- 
traoocyte CAMP concentration is l-2 pM per oocyte 
[28,29], with large fluctuations from one frog to an- 
other. This could explain the variation of the amplitude 
of the basal Ba current in oocytes from different 
animals. We observed that the absolute amplitude 1, 
can reach in the presence of CAMP (using supramaximal 
concentration) was not dependent on the value of the 
basal current (Fig. 4B), as if the total number of 
channels available for opening after CAMP action was 
similar on all oocytes. 
4. CONCLUSIONS 
Xenopus oocytes possess a variable pool of en- 
dogenous VDCC which pharmacologically is clearly 
different from the previously-described T, L, N and P 
type calcium channels ([lo,131 and this work). However, 
these endogenous (high threshold) channels hare some 
similarities with the L type when PKA- or PKC-de- 
pendent regulation is considered. Basal PKA activity 
seems to control the level of Ca entry into stage VI 
Xenopus oocytes. To conclude, it should be noted that 
such regulation of endogenous VDCC could constitute 
a drawback to study the regulation of expressed Ca 
channels. However, our work has been conducted on 
oocytes displaying unusually large (~10 nA) en- 
dogenous Ba currents. Most of the oocytes did not 
possess uch Ca channel activity, even after CAMP in- 
jection. In some batches of oocytes, devoid of Ba 
current, prior injection of CAMP (50 PM), purified pro- 
tein kinase A holoenzyme (0.25 pg/oocyte), or both, did 
not produce any current (n=S; not shown), suggesting 
that another regulation at the transcriptional and/or 
translational level may exist. 
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